Yuki Homma

8PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersGastroenterology and hepatologyCancer therapy (excl. chemotherapy and radiation therapy)Medical ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 03, 2026
A Machine Learning Model for Predicting Posthepatectomy Liver Failure After Hepatectomy With Extrahepatic Bile Duct Resection for Perihilar Cholangiocarcinoma: With and Without Indocyanine Green.

|May 18, 2026
Preoperative Aortic Calcification Volume Predicts Postoperative Complications in Nonpancreatic Cancer Patients Undergoing Pancreaticoduodenectomy.

|Jun 25, 2025
Prognostic Significance of Post-Neoadjuvant Chemotherapy Carbohydrate Antigen 19-9 Levels in Patients With Resectable Pancreatic Cancer Treated With S-1 and Gemcitabine: A Retrospective Cohort Study.

Yuki Homma, Kentaro Miyake, Yutaro Kikuchi

|Jan 06, 2025
Novel machine-learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma.

Susumu Daibo, Yuki Homma, Hiroki Ohya

|Oct 26, 2023
A multi-institutional study designed by members of Tokyo Guidelines (TG) Core Meeting to elucidate the clinical characteristics and pathogenesis of acute cholangitis after bilioenteric anastomosis and biliary stent insertion with a focus on biliary obstruction: Role of transient hepatic attenuation difference (THAD) and pneumobilia in improving TG diagnostic performance.

Hiroyuki Kato, Tadahiro Takada, Steven Strasberg

|Sep 30, 2022
Outcomes of neoadjuvant gemcitabine plus S-1 and radiation therapy for borderline resectable pancreatic cancer.

Yasuhiro Yabushita, Ryusei Matsuyama, Kentaro Miyake

Pageof 2

Frequent Collaborators

5 joint publications

Itaru Endo

3 joint publications

Shugo Mizuno

2 joint publications

Shuji Isaji

2 joint publications

Koji Asai